Quantitative proteomics identifies clusterin as a novel biomarker for atherosclerosisOA
Quantitative proteomics identifies clusterin as a novel biomarker for atherosclerosis
Dengfeng Ding;Tao Jiang;Yuqiong Zhao;Yingjie Zhang;Li Zhang;Xinou Zheng;Miaomiao Niu;Yunxiao Jia;Xuezhuang Li;Hua Chen;Chao Guo
Medical Innovation Research Department,Chinese PLA General Hospital,Beijing,ChinaMedical Innovation Research Department,Chinese PLA General Hospital,Beijing,ChinaMedical Innovation Research Department,Chinese PLA General Hospital,Beijing,ChinaDepartment of Nephrology,First Medical Center of Chinese PLA General Hospital,Nephrology Institute of the Chinese People's Liberation Army,State Key Laboratory of Kidney Diseases,Beijing,ChinaBeijing Engineering Research Center for Experimental Animal Models of Human Diseases,Peking Union Medicine College,Beijing,ChinaMedical Innovation Research Department,Chinese PLA General Hospital,Beijing,ChinaMedical Innovation Research Department,Chinese PLA General Hospital,Beijing,ChinaMedical Innovation Research Department,Chinese PLA General Hospital,Beijing,ChinaMedical Innovation Research Department,Chinese PLA General Hospital,Beijing,ChinaMedical Innovation Research Department,Chinese PLA General Hospital,Beijing,ChinaMedical Innovation Research Department,Chinese PLA General Hospital,Beijing,China
AKTatherosclerosisclusterinLRP1proteomics
AKTatherosclerosisclusterinLRP1proteomics
《动物模型与实验医学（英文）》 2026 (4)
685-697,13
National Natural Science Foundation of China,Grant/Award Number:32370568
评论